277 related articles for article (PubMed ID: 25457157)
21. [Expression of promyelocytic leukaemia protein in lung carcinomas and clinical significance thereof].
Zhao ZL; Huang QY; Xu S; Zhang L; Zhao HR
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3362-6. PubMed ID: 17313836
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis.
Ouyang J; An T; Wang Y; Lu X; Zhang Y; Wang X; Zhang X; Zhang C
Diagn Pathol; 2021 Dec; 16(1):113. PubMed ID: 34895274
[TBL] [Abstract][Full Text] [Related]
23. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
24. The embryonic Brachyury transcription factor is a novel biomarker of GIST aggressiveness and poor survival.
Pinto F; Campanella NC; Abrahão-Machado LF; Scapulatempo-Neto C; de Oliveira AT; Brito MJ; Andrade RP; Guimarães DP; Reis RM
Gastric Cancer; 2016 Apr; 19(2):651-659. PubMed ID: 25995035
[TBL] [Abstract][Full Text] [Related]
25. Proteomic Maps of Human Gastrointestinal Stromal Tumor Subgroups.
Liu Y; Li Z; Xu Z; Jin X; Gong Y; Xia X; Yao Y; Xu Z; Zhou Y; Xu H; Li S; Peng Y; Wu X; Dai L
Mol Cell Proteomics; 2019 May; 18(5):923-935. PubMed ID: 30804049
[TBL] [Abstract][Full Text] [Related]
26. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.
Patrikidou A; Domont J; Chabaud S; Ray-Coquard I; Coindre JM; Bui-Nguyen B; Adenis A; Rios M; Bertucci F; Duffaud F; Chevreau C; Cupissol D; Pérol D; Emile JF; Blay JY; Le Cesne A;
Eur J Cancer; 2016 Jan; 52():173-80. PubMed ID: 26687836
[TBL] [Abstract][Full Text] [Related]
28. LIX1 regulates YAP activity and controls gastrointestinal cancer cell plasticity.
Guérin A; Martire D; Trenquier E; Lesluyes T; Sagnol S; Pratlong M; Lefebvre E; Chibon F; de Santa Barbara P; Faure S
J Cell Mol Med; 2020 Aug; 24(16):9244-9254. PubMed ID: 32633461
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
Liang YM; Li XH; Li WM; Lu YY
World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of Atoh1 correlates with favorable survival in gastrointestinal stromal tumor.
Huang H; Zhai X; Zhu H; Wang W; Zhang S; Wu L; Zhang J
Int J Clin Exp Pathol; 2014; 7(10):7123-30. PubMed ID: 25400808
[TBL] [Abstract][Full Text] [Related]
31. [Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases].
Yang J; Yu J; Ma Z; Kang W; Tian S; Ye X
Zhonghua Wai Ke Za Zhi; 2015 Apr; 53(4):274-9. PubMed ID: 26269161
[TBL] [Abstract][Full Text] [Related]
32. Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein.
Xu Z; Chen J; Shao L; Ma W; Xu D
Tumour Biol; 2015 Sep; 36(10):8047-54. PubMed ID: 25971581
[TBL] [Abstract][Full Text] [Related]
33. High expression of G protein subunit gamma 13 is associated with poor prognosis of gastrointestinal stromal tumor.
Ju KC; Zhang B; Hu YL; Feng Y; Li XH; Liu YF; Li P; Mao QS; Xue WJ
Pathol Res Pract; 2020 Oct; 216(10):153143. PubMed ID: 32853961
[TBL] [Abstract][Full Text] [Related]
34. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
35. High APRIL expression correlates with unfavourable survival of gastrointestinal stromal tumour.
Xian H; Zhang H; Zhu H; Wang X; Tang X; Mao Y; Zhu J
Pathology; 2014 Dec; 46(7):617-22. PubMed ID: 25393252
[TBL] [Abstract][Full Text] [Related]
36. The GIST paradigm: how to establish diagnostic and prognostic criteria.
Calabuig-Farinas S; Lopez-Guerrero JA; Llombart-Bosch A
Arkh Patol; 2011; 73(4):13-21. PubMed ID: 22164425
[TBL] [Abstract][Full Text] [Related]
37. Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor.
Kubota D; Yoshida A; Tsuda H; Suehara Y; Okubo T; Saito T; Orita H; Sato K; Taguchi T; Yao T; Kaneko K; Katai H; Kawai A; Kondo T
PLoS One; 2013; 8(8):e73896. PubMed ID: 23977394
[TBL] [Abstract][Full Text] [Related]
38. [Morphological characteristics and prognostic criteria for gastrointestinal stromal tumors].
Tsyganova IV; Anurova OA; Mazurenko NN
Arkh Patol; 2011; 73(6):37-42. PubMed ID: 22379899
[TBL] [Abstract][Full Text] [Related]
39. Comparing the long-term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: An analysis of the National Cancer Database.
Giuliano K; Ejaz A; Reames BN; Choi W; Sham J; Gage M; Johnston FM; Ahuja N
J Surg Oncol; 2018 Sep; 118(3):486-492. PubMed ID: 30129672
[TBL] [Abstract][Full Text] [Related]
40. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.
Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y
Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
